Insights

Strategic Briefings

A monthly briefing on Diagnostic and MedTech growth strategy, regulatory sequencing, and clinical adoption architecture.

Market AccessFeatured Briefing

The Adoption Paradox: Why Diagnostic Innovation Is Accelerating while Clinical Integration Is Slowing

An analysis of the widening chasm between FDA clearance and sustainable clinical revenue. We explore the structural failures in traditional launch sequencing and the architectural shifts required to turn scientific validation into repeatable adoption.

By Scott RobitailleRead Briefing

Market Access

Market Access Architecture: A Blueprint for Repeatable Clinical Adoption

A structured methodology for turning scientific validation into scalable clinical revenue.

Reimbursement

Diagnostic Reimbursement Strategy: What Founders Get Wrong

Why reimbursement must be designed before launch, not after.

Reimbursement

Clinical Utility vs Clinical Validation: What Actually Drives Adoption

Understanding what payers and providers actually require to change behavior.

DiagnosticsStatus: Forthcoming

Why Pilot Programs Fail to Scale in Diagnostics

Early traction is not product-market fit. What it takes to move beyond pilots.

Next Step

Navigating the commercialization window

AdvisoryDx works with founders and investors to design and install the commercial architecture required for repeatable adoption.